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Ovarian cancer presenting as an acute abdomen was successfully diagnosed
and managed by laparoscopyA 42-year-old, gravida 2, para 2 woman had suffered from
abdominal pain for 1 day. Her history includes two cesarean
sections, and a 4-year experience of dysmenorrhea. She was
diagnosed accidentally to have a 6-cm ovarian tumor favoring
the diagnosis of chocolate cyst (endometrioma) 6 months ago.
Her last menstruation date was 29 days ago; therefore, she
considered this acute abdominal pain as dysmenorrhea since
this attack was accompanied with menstruation.
Transvaginal ultrasound revealed an 80  75  80 mm
cyst with little echogenicity on the right adnexal area. Her
urine pregnancy test was negative. Other laboratory exami-
nations were within normal limits, except for leukocytosis of
12,300.
Diagnostic and therapeutic laparoscopy was suggested due
to failed response to pain-relieving medication after a 24-hour
observation, and clinical diagnosis was the suspicious ruptured
or twisted right ovarian chocolate cyst. Laparoscopy showed
a dark-red cystic lesion covered by the surrounding omentum.
After carefully dissecting the tumor from the surrounding
omentum, the diagnosis of tubo-ovarian torsion was made.
Then, laparoscopic salpingo-oophorectomy was performed
with complete removal of the intact tumor using a cellulose
bag through an enlarged umbilical wound. Frozen pathology
favored benign ovarian tumor. However, the final pathology
showed mucinous ovarian cancer grade 2. After a careful and
thorough discussion and postoperative evaluation, the patient
received four-course adjuvant chemotherapy with a combina-
tion of paclitaxel and carboplatin, and has been disease-free
for 59 months so far.
In this case report, the following interesting issues are
raised. First, we completely agree with Dr. Lee’s previous
comment that great advances in technology offer meticulous
options of minimally invasive surgery to empower the gyne-
cologists to manage patients with early ovarian cancer [1],
although this issue is still highly debated. Recent studies only
suggested that laparoscopic surgery might be used in the
management of endometrial cancers, especially type I endo-
metrial cancer (endometrioid carcinoma of the uterus) and/or
early-stage cervical cancers, which had better be limited to
IB1 and tumor size better be less than 2 cm [2,3]. By contrast,
the development of robot-assisted laparoscopy system might1028-4559/$ - see front matter Copyright  2012, Taiwan Association of Obstetri
doi:10.1016/j.tjog.2012.01.034overcome the technical limitations in conventional laparos-
copy, and provide an opportunity in the management of
difficult gynecologic surgeries [4,5], including gynecological
cancers [6,7].
Second, is surgical restaging indicated in apparent stage IA
epithelial ovarian cancer? To respond to this question is not easy.
During primary surgery for advanced-stage epithelial ovarian
cancer, all attempts should be made to achieve complete
cytoreduction, since women with residual disease<1 cm still do
better than women with residual disease>1 cm [8]. When this is
not achievable, then the surgical goal should be optimal (<1 cm)
residual disease [8]. However, this application might not be
appropriate for apparent stage IA epithelial ovarian cancer, since
postoperative adjuvant chemotherapy seems to improve the
outcome of patients with early-stage epithelial ovarian cancers,
even though these patients were treated with fertility-sparing
surgery [9].
We conclude that although reoperation is suggested in the
majority of patients with accidental diagnosis of ovarian
malignancy, for highly selected patients, including those with
apparent stage IA epithelial ovarian cancer, removal of the
intact tumor without malpractice or overmanipulation, post-
operative adjuvant chemotherapy, and good compliance of close
follow-up, laparoscopic surgery might not compromise the
outcome of these patients.References
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